Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis

Collet, E., Dalac, S., Maerens, B., Courtois, J.M., Izak, M. and Lambert, D. Juvenile dermatomyositis: treatment with intravenous gammaglobulin. Br J Dermatol, 1994, 130, 2312–234.

Cherin, P., Herson, S., Wenchsler, B. et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymiositis and dermatomiositis: an open study with 20 adult patients. Am J Med, 1991, 91, 162–8.

Lang, B.A., Laxer, R.M., Murphy, G. et al. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med, 1991, 91, 169–72.

Ronda, N., Hurez, V., Kazatchkine, M.D. et al. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases. Vox Sang, 1993, 64, 65–72.

Francioni, C., Galeazzi, M., Fioravanti, A., Gelli, R., Megale, F., Marcolongo, R. Long term IVIg treatment in systemic lupus erythematosus. Clin Exp Rheumatol, 1994, 12, 163–168.

Jayne, D.R.W., Davies, M.G., Fox, C.J.V., Black, C.M., Lockwood, C.M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet, 1991, 2, 1137–9.

Mannhalter, J.W., Eibl, M.M. Down regulation of Fc receptors by IVIgG. Intern Rev Immunol, 1989, 5, 173.

Ronda, N., Hurez, V., Kazatchkine, M.D. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory disease. Vox Sang 1993, 64, 65–72.

Basta, M., Kirschbom, P., Frank, M.M., Fries, L.F. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model. J Clin Invest 1989, 84, 1974–81.

Jobin, D., Kazatchkine, M. Immunoglobulines intraveineuses (IVIG) et suppression anti-idiotypique de l'autoimmunitè. Rev Med Interne, 1992, 13, 162–5.

Rossi, F., Dietrich, G., Kazatchine, M.D. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence of network regulation of human autoimmune responses. Immunol Rev, 1989, 110, 135–49.

Rossi, F., Jayne, D.R.W., Lockwood, C.M. et al. Antiidiotypes against antineutrophil cytoplasm antigen autoantibodies in normal human polyspecific IgG for therapeutic rise and the remission sera of patients with systemic vasculitis. Clin Exp Immunol 1991, 83, 1–6.

Oates, J.A., Wood, A.J.J. Manipulating the immune system with immune globulin. N Engl J Med 1992, 326, 107–16.

Ronda, N., Naveri, S.V., Nazatchkine, M.D. Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotype network. Proceedings of the 5th International ANCA Workshop, Cambridge, UK, September 1993, pp. 1415.